Human cardiovascular disease model predicts xanthine oxidase inhibitor cardiovascular risk.
Feaver RE, Bowers MS, Cole BK, Hoang S, Lawson MJ, Taylor J, LaMoreaux BD, Zhao L, Henke BR, Johns BA, Nyborg AC, Wamhoff BR, Figler RA.
Feaver RE, et al. Among authors: zhao l.
PLoS One. 2023 Sep 8;18(9):e0291330. doi: 10.1371/journal.pone.0291330. eCollection 2023.
PLoS One. 2023.
PMID: 37682977
Free PMC article.
Clinical Trial.